PuSH - Publikationsserver des Helmholtz Zentrums München

Bertrand, R.* ; Hamp, I.* ; Brönstrup, M.* ; Weck, R.* ; Lukacevic, M.* ; Polyak, A.* ; Ross, T.L.* ; Gotthardt, M.* ; Plettenburg, O. ; Derdau, V.*

Synthesis of GPR40 targeting 3H- and 18F-probes towards selective beta cell imaging.

J. Labelled Comp. Radiopharm. 59, 604-610 (2016)
DOI PMC
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Diabetes affects an increasing number of patients worldwide and is responsible for a significant rise in healthcare expenses. Imaging of β-cells in vivo is expected to contribute to an improved understanding of the underlying pathophysiology, improved diagnosis, and development of new treatment options for diabetes. Here, we describe the first radiosyntheses of [(3) H]-TAK875 and [(18) F]-TAK875 derivatives to be used as β-cell imaging probes addressing the free fatty acid receptor 1 (FFAR1/GPR40). The fluorine-labeled derivative showed similar agonistic activity as TAK875 in a functional assay. The radiosynthesis of the (18) F-labelled tracer 2a was achieved with 16.7 ± 5.7% radiochemical yield in a total synthesis time of 60-70 min.
Altmetric
Weitere Metriken?
[➜Einloggen]
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Korrespondenzautor
Schlagwörter Gpr40 ; Beta Cell Imaging ; Fluorine-18 ; Tritium; Positron-emission-tomography; Type-2 Diabetes-mellitus; Ene Click Chemistry; Free Fatty-acids; Receptor; Discovery; Tak-875; Agonist
ISSN (print) / ISBN 0362-4803
e-ISSN 1099-1344
Zeitschrift Journal of Labelled Compounds and Radiopharmaceuticals
Quellenangaben Band: 59, Heft: 14, Seiten: 604-610 Artikelnummer: , Supplement: ,
Verlag Wiley
Verlagsort Hoboken
Nichtpatentliteratur Publikationen
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Medicinal Chemistry (IMC)